Results 1 to 10 of about 365,692 (312)

Integrating Sexual and Reproductive Health Services Within HIV Services: WHO Guidance

Frontiers in Global Women's Health, 2021
Among the 1.9 billion women of reproductive age worldwide in 2019, 1.1 billion need family planning and 270 million have an unmet need for contraception.
Nathan Ford, Morkor Newman, Sarai Malumo, Lastone Chitembo, Mary E. Gaffield   +4 more
doaj   +1 more source

Mutation of Mycobacterium tuberculosis and Implications for Using Whole-Genome Sequencing for Investigating Recent Tuberculosis Transmission

Frontiers in Public Health, 2022
Tuberculosis (TB) control programs use whole-genome sequencing (WGS) of Mycobacterium tuberculosis (Mtb) for detecting and investigating TB case clusters. Existence of few genomic differences between Mtb isolates might indicate TB cases are the result of
Kristin N. Nelson, Sarah Talarico, Shameer Poonja, Clinton J. McDaniel, Martin Cilnis, Alicia H. Chang, Kala Raz, Wendy S. Noboa, Lauren Cowan, Tambi Shaw, James Posey, Benjamin J. Silk   +11 more
doaj   +1 more source

The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?

Frontiers in Immunology, 2021
IL-36 is a member of the interleukin 1 cytokine family, which is currently experiencing a renaissance due to the growing understanding of its context-dependent roles and advances in our understanding of the inflammatory response.
Xiaofang Wang, Xiaofang Wang, Panpan Yi, Yuejin Liang, Yuejin Liang   +4 more
doaj   +1 more source

Antiviral activity of zinc against hepatitis viruses: current status and future prospects

Frontiers in Microbiology, 2023
Viral hepatitis is a major public health concern globally. World health organization aims at eliminating viral hepatitis as a public health threat by 2030.
Shiv Kumar, Shabnam Ansari, Sriram Narayanan, C. T. Ranjith-Kumar, Milan Surjit   +4 more
doaj   +1 more source

Research progress on anti-viral treatment for chronic hepatitis B patients with high viral load [PDF]

Xin yixue, 2022
Chronic hepatitis B （CHB） is a severe disease that affects human health. Replication of hepatitis B virus （HBV） is the main cause of morbidity in CHB patients.
Peng Wan, Cao Hong
doaj   +1 more source

Hepatitis A Virus Strains Circulating in the Campania Region (2015–2018) Assessed through Bivalve Biomonitoring and Environmental Surveillance

Viruses, 2020
The genetic diversity of Hepatitis A Virus (HAV) circulating in the Campania Region in years 2015–2018 was investigated through the monitoring of sentinel bivalve shellfish and water matrices.
Giuseppina La Rosa, Pamela Mancini, Giusy Bonanno Ferraro, Marcello Iaconelli, Carolina Veneri, Rosa Paradiso, Dario De Medici, Teresa Vicenza, Yolande Therese Rose Proroga, Orlandina Di Maro, Anna Rita Ciccaglione, Roberto Bruni, Michele Equestre, Stefania Taffon, Angela Costantino, Maurizio Della Rotonda, Elisabetta Suffredini   +16 more
doaj   +1 more source

Role of bioactive compounds in the treatment of hepatitis: A review

Frontiers in Pharmacology, 2022
Hepatitis causes liver infection leading to inflammation that is swelling of the liver. They are of various types and detrimental to human beings. Natural products have recently been used to develop antiviral drugs against severe viral infections like ...
Arpita Roy, Madhura Roy, Amel Gacem, Shreeja Datta, Md. Zeyaullah, Khursheed Muzammil, Thoraya A. Farghaly, Magda H. Abdellattif, Krishna Kumar Yadav, Jesus Simal-Gandara   +9 more
doaj   +1 more source

Epidemiology of chronic hepatitis B and C in Victoria, Australia: insights and impacts from enhanced surveillance

Australian and New Zealand Journal of Public Health, 2020
Objective: To assess the impact of an enhanced viral hepatitis surveillance program on data completeness and on epidemiological assessment of affected populations.
Jennifer H. MacLachlan, Nicole Romero, Nasra Higgins, Rachel Coutts, Rachel Chan, Nicola Stephens, Benjamin C. Cowie   +6 more
doaj   +1 more source

Human genetic basis of fulminant viral hepatitis [PDF]

Human Genetics, 2020
In rare cases, hepatitis A virus (HAV) and hepatitis B virus (HBV) can cause fulminant viral hepatitis (FVH), characterized by massive hepatocyte necrosis and an inflammatory infiltrate. Other viral etiologies of FVH are rarer. FVH is life-threatening, but the patients are typically otherwise healthy, and normally resistant to other microbes.
openaire   +2 more sources

Molecular Identification of HIV-1 in the Presence of Hepatitis B Virus and Hepatitis C Virus Co-infections

Balkan Medical Journal, 2020
Background: Because of their similar modes of transmission, the simultaneous infection of viral hepatitis and human immunodeficiency virus are increasingly seen as a big problem related to human health. Aims: To determine the drug mutations in hepatitis
Müge Özgüler, Figen Sarıgül Yıldırım, Taner Yıldırmak, Alper Gündüz, Başak Dokuzoğuz, Mustafa Kemal Çelen, Dilara İnan, Yasemin Heper, Gülden Ersöz, İlkay Karaoğlan, Nurgül Ceran, Aydın Deveci, Servet Öztürk, Selda Sayın Kutlu, Hülya Özkan Özdemir, Ayhan Akbulut, Saadet Yazıcı, Alper Şener, Atahan Çağatay, Serhat Ünal   +19 more
doaj   +1 more source